Neurocrine Biosciences, announced the appointment of Sanjay Keswani, M.D., to the company's executive management team as Chief Medical Officer (CMO) effective June 2, 2025. Dr. Keswani, an...
Platform developed in collaboration with CRScube, capitalizing on learnings from world-leading pharma and biotech companies
Perceptive eClinical, part of Perceptive Group, is pleased to announce the...
Xaira Therapeutics announced the appointment of Dr. Debbie Law to its C-suite. Law will serve as chief scientific officer.
Xaira Therapeutics launched in April on...
Leyden Laboratories B.V., a biotechnology company working to free people from the threat of respiratory viruses by boosting mucosal immunity, announced the appointment of...
Boehringer Ingelheim and OSE Immunotherapeutics SA (OSE), a clinical stage biotech company, announced that Boehringer will be progressing their first-in-class SIRPα immuno-oncology program into...